USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: EPIGEN BIOSCIENCES, INC.
City: SAN DIEGO
State: CA
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $677,900.00 2
STTR Phase I $726,746.00 1

Award List:

Drug regulators of nitric oxide production as Alzheimer's disease therapeutics

Award Year / Program / Phase: 2012 / STTR / Phase I
Agency: HHS
Research Institution: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Principal Investigator: John A. Schetz – 817-735-2064
Award Amount: $726,746.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Druggable regulators of nitric oxide production as new Alzheimer's disease therapeutics Summary: Nitrosative stress is a critical mediator of the onset and progression of Alzheimer's disease (AD): it precedes and is associated with neuritic dystrophy… More

Selective LPA1 receptor antagonists as agents in prevention of renal fibrosis

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Fabio C. Tucci – 619-917-0639
Award Amount: $389,603.00
Abstract:
DESCRIPTION (provided by applicant): The ultimate goal of our project is to develop novel therapeutics effective in chronic kidney diseases that normally develop fibrosis, lead to end stage renal disease and require renal replacement therapy. This will beachieved by identifying novel selective… More

High-specificity affinity reagents for N-glycosylation site mapping and glycomics

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Fabio C. Tucci – 619-917-0639
Award Amount: $288,297.00
Abstract:
DESCRIPTION (provided by applicant): Metastasis is a key factor for poor prognosis in cancer patients. Breast cancer is the most common invasive cancer in women and the second-most common cause of death in American women. Triple negative breast cancer tends to be both unresponsive to chemotherapy… More